Sabatino Pallotta - IDI - Istituto Dermopatico dell'Immacolata

Dr.

Sabatino

Pallotta

Ruolo in Idi

Direttore Unità Operativa Complessa

Ambulatorio

Dermatologia clinica

Dermatologia clinica

Degenza

Dermatologia Day Surgery

Dermatologia, Day Hospital Allergologico, Dermatologia Day Hospital, Dermatologia Day Surgery

Specializzazione

Dermatologo

Localizzazione

Attività di Servizio Sanitario Nazionale

Si

Attività di Ambulatorio Privato

Si

Lingue parlate

Italiano, Inglese

Contatti

Expertise clinica

Direttore Dipartimento di Dermatologia IDI-IRCCS

Biografia

1994 Diploma di specializzazione in Dermatologia e Venereologia presso la Scuola di Specializzazione dell’Università “La Sapienza” di Roma con votazione di 70/70 e Lode.
1996 Vincitore di concorso per l’ammissione al corso biennale di formazione specifica in Medicina Generale relativo agli anni 1994-1995.
2004 Diploma di specializzazione in Reumatologia presso la Scuola di Specializzazione dell’Università di Siena con votazione di 70/70 e Lode. Tesi sperimentale dal titolo: “Aspetti Patogenetici della Sclerodermia Sistemica”.

Attività didattica e scientifica

Pubblicazioni

2024 - Frontiers in immunology - Identification of immunological patterns characterizing immune-related psoriasis reactions in oncological patients in therapy with anti-PD-1 checkpoint inhibitors.

2024 Mar 14 - Dermatitis : contact, atopic, occupational, drug - Paradoxical Head and Neck Erythema in Patients Treated With Dupilumab: Not Only Red Face.

2024 Apr - Expert opinion on drug safety - Dupilumab in real-life settings: a review of adverse events and their pathogenesis.

2024 Feb 24 - Journal of the European Academy of Dermatology and Venereology : JEADV - The impact of COVID-19 pandemic on the number of first diagnosis and follow-up visits of patients affected by pemphigus, bullous pemphigoid, scleroderma, psoriasis and vitiligo: A single-centre experience.

2024 Jan-Feb - Dermatitis : contact, atopic, occupational, drug - Emerging Role of Atopic Dermatitis Control Tool in Long-Term Monitoring of Patients With Moderate-to-Severe Atopic Dermatitis Treated With Dupilumab.

2023 Jul 2 - Biomolecules - Systemic Photoprotection in Melanoma and Non-Melanoma Skin Cancer.

2023 Dec - The Journal of dermatological treatment - Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study.

2023 Jan-Jun - Expert opinion on investigational drugs - The holistic approach to psoriasis patients with comorbidities: the role of investigational drugs.

2023 Sep - Archives of dermatological research - Comparison of self-reported and measured height and weight in patients with psoriasis.

2022 Nov 1 - European journal of dermatology : EJD - Melanoma on tattoos: a case study and review of the literature.

2022 Dec 16 - Science advances - Extracellular serine empowers epidermal proliferation and psoriasis-like symptoms.

2022 - Frontiers in medicine - Case report: A rare case of imiquimod-induced atypical pemphigus vulgaris.

2022 Sep 14 - Dermatology reports - Attitudes among dermatologists regarding actinic keratosis treatment options.

2022 - Frontiers in cardiovascular medicine - Extracellular Nucleophosmin Is Increased in Psoriasis and Correlates With the Determinants of Cardiovascular Diseases.

2022 Jun - Dermatologic therapy - Tildrakizumab in moderate-to-severe plaque psoriasis: A multicenter, retrospective, real-life study.

2022 - Frontiers in medicine - Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study.

2022 Jul - Journal of the American Academy of Dermatology - Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter study.

2021 - Frontiers in psychology - Multi-Method Approach in the Assessment of Alexithymia in Patients With Scleroderma: Use of Two Different Tools.

2021 Oct 2 - Cells - PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis.

2021 Aug 1 - Dermatology reports - Integrated care pathways and the hub-and-spoke model for the management of non-melanoma skin cancer: A proposal of the Italian Association of Hospital Dermatologists (ADOI).

2021 Aug 18 - Journal of clinical medicine - Pain as Defining Feature of Health Status and Prominent Therapeutic Target in Patients with Hidradenitis Suppurativa.

2021 Jun 25 - International journal of molecular sciences - Enhanced NAMPT-Mediated NAD Salvage Pathway Contributes to Psoriasis Pathogenesis by Amplifying Epithelial Auto-Inflammatory Circuits.

2021 Feb 23 - Biomolecules - Systemic Photoprotection in Skin Cancer Prevention: Knowledge among Dermatologists.

2021 Feb 12 - European journal of dermatology : EJD - Scarce knowledge of systemic photoprotection among skin cancer patients: a cross-sectional survey.

2020 Dec - Recenti progressi in medicina - [The integrated care pathway for non melanoma skin cancer: the Istituto Dermopatico dell'Immacolata - IRCCS experience in Rome.].

2021 Feb - Expert opinion on biological therapy - HLA-Cw6 and other HLA-C alleles, as well as MICB-DT, DDX58, and TYK2 genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis.

2020 Oct 23 - Biomedicines - Basal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.

2020 Oct 8 - Dermatology online journal - Granuloma inframammary adultorum, a case report.

2020 Nov 12 - Acta dermato-venereologica - Correlation between Depression, Quality of Life and Clinical Severity in Patients with Hidradenitis Suppurativa.

2020 Nov - Dermatologic therapy - Intralesional ultrasound-guided combined treatment with triamcinolone plus lincomycin in hidradenitis suppurativa: A pilot study.

2020 Apr 17 - Aging - Intracellular Insulin-like growth factor binding protein 2 (IGFBP2) contributes to the senescence of keratinocytes in psoriasis by stabilizing cytoplasmic p21.

2020 Apr 10 - European journal of dermatology : EJD - The International Hidradenitis Suppurativa Severity Score System (IHS4) is a valuable tool to assess gender-associated differences.

2019 Dec - The Journal of dermatology - Use of the SF-12 questionnaire to assess physical and mental health status in patients with psoriasis.

2019 Nov - Clinical rehabilitation - A comparison between two educational methods in the rehabilitation of the microstomia in systemic sclerosis: a randomized controlled trial.

2019 - Dermatology (Basel, Switzerland) - The Broad-Spectrum Impact of Hidradenitis Suppurativa on Quality of Life: A Comparison with Psoriasis.

2021 Apr - Italian journal of dermatology and venereology - High melanoma risk in non-melanoma skin cancer patients under age 40: a large retrospective cohort study.

2018 - Journal of immunology research - Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis.

2018 Feb 1 - European journal of dermatology : EJD - Age-specific prevalence of psoriasis in an unselected sample of 25,956 Italian hospital inpatients: evidence for selective excess mortality after 70 years of age.

2011 May-Jun - European journal of dermatology : EJD - Pemphigus foliaceous with thymoma and multiple comorbidities: a fatal case.

2010 Aug 15 - Journal of immunology (Baltimore, Md. : 1950) - The IFN-gamma-dependent suppressor of cytokine signaling 1 promoter activity is positively regulated by IFN regulatory factor-1 and Sp1 but repressed by growth factor independence-1b and Krüppel-like factor-4, and it is dysregulated in psoriatic keratinocytes.

2009 Dec - The Journal of clinical investigation - Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

2009 Jan 16 - The Journal of experimental medicine - Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment.

2002 Nov-Dec - European journal of dermatology : EJD - Pruritic eosinophilic papular eruption revealing HIV infection.

Numeri utili:

CUP

Assicurazione e Attività Privata

Numeri utili: CUP06 6646 4094,

Assicurazione e Attività Privata 06 6646 4499

© Fondazione Luigi Maria Monti – Sede Legale: Via Monti di Creta 104, 00167 Roma – PEC: fondazioneluigimariamonti@legalmail.it – CF 97831400581 – PI 13326621003
Informative e Privacy – Gestisci Cookie – Social media policy – Limitazione di responsabilità

Sito aggiornato al 24/04/2024 ore 12:16

SHORT LINK

La ricerca in IDI è finanziata da:

I NOSTRI SOCIAL

© Fondazione Luigi Maria Monti – Sede Legale: Via Monti di Creta 104, 00167 Roma – PEC: fondazioneluigimariamonti@legalmail.it – CF 97831400581 – PI 13326621003
Informative e Privacy – Gestisci Cookie – Social media policy – Limitazione di responsabilità

Sito aggiornato al 24/04/2024 ore 12:16

Powered by

Powered by